XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122 Nov 10, 2008 8:01am EST
XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11 Nov 04, 2008 7:00am EST
XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10 Nov 04, 2008 7:00am EST
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models Oct 25, 2008 8:00pm EDT
XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25 Sep 22, 2008 8:05am EDT
